BRISTOL, TN / ACCESS Newswire / October 7, 2025 / Quantum BioPharma Ltd. (QNTM)(FRA:0K91) is quietly redrawing the boundaries of what a biotechnology company can be. The company has evolved beyond ...
Microsize brings over thirty years of expertise in specialized particle size engineering for the pharmaceutical industry, from pre-clinical development to full-scale GMP commercial manufacturing.
RICHMOND, Va. (WRIC) — Nadia Tasnim Ahmed, a student at Virginia Commonwealth University (VCU) in Richmond, will soon become the first person in America to have a Ph.D in pharmaceutical engineering.
The International Society for Pharmaceutical Engineering (ISPE) has announced its keynote speakers for the 2026 ISPE Aseptic Conference, set for Monday, 23 March, through Tuesday, 24 March, in ...
Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...
Setting new standards in responsible innovation, CSL's Broadmeadows facility blends Pharma 4.0™ principles with sustainable design to transform plasma manufacturing Purpose-built to optimise the ...
Pharmaplan fully integrated into Exyte, unifying biopharma engineering capabilities under one European organization. Integrated setup drives strong client demand and a record order-intake level in ...
Hosted on MSN
Fabtech Technologies IPO opens for subscription. Check GMP, price band and other details
Fabtech Technologies, a biopharma engineering solutions provider, has launched its IPO on September 29. The Rs 230 crore issue, entirely a fresh issue of 1.21 crore shares, will close on October 1.
Hosted on MSN
Fabtech Technologies IPO Day 1: Check subscription status, GMP, price band and key highlights
Fabtech Technologies, a specialist in biopharma engineering solutions, launched its initial public offering (IPO) on Monday, September 29. Early bidding on the first day saw a modest overall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results